BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38626166)

  • 1. Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    Dua R; Bhardwaj T; Ahmad I; Somvanshi P
    PLoS One; 2024; 19(4):e0287864. PubMed ID: 38626166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
    Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
    Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Expression of miRNAs Related to Female Flower Induction in Walnut (
    Zhou L; Quan S; Xu H; Ma L; Niu J
    Molecules; 2018 May; 23(5):. PubMed ID: 29772800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
    Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
    Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.
    Salaria D; Rolta R; Mehta J; Awofisayo O; Fadare OA; Kaur B; Kumar B; Araujo da Costa R; Chandel SR; Kaushik N; Choi EH; Kaushik NK
    PLoS One; 2022; 17(3):e0265420. PubMed ID: 35298541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
    Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial.
    Hosseini S; Jamshidi L; Mehrzadi S; Mohammad K; Najmizadeh AR; Alimoradi H; Huseini HF
    J Ethnopharmacol; 2014 Mar; 152(3):451-6. PubMed ID: 24462785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic Approach.
    Poleboyina PK; Alagumuthu M; Pasha A; Ravinder D; Pasumarthi D; Pawar SC
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7766-7795. PubMed ID: 37086377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.
    Kolur V; Vastrad B; Vastrad C; Kotturshetti S; Tengli A
    BMC Cardiovasc Disord; 2021 Jul; 21(1):329. PubMed ID: 34218797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.
    Sun D; Han L; Cao R; Wang H; Jiang J; Deng Y; Yu X
    FEBS Open Bio; 2019 Dec; 9(12):2080-2092. PubMed ID: 31642613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential mechanism of Guizhi Fuling Wan effect in the treatment of cervical squamous cell carcinoma: A bioinformatics analysis investigation.
    Wang X; Wang T; Jiang X; Ruan Y; Wang J; Qi C
    Medicine (Baltimore); 2024 Feb; 103(5):e37153. PubMed ID: 38306566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
    Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing pathway-related modules in invasive squamous cervical cancer based on topological centrality of network strategy.
    Fu XH; Wu YF; Xue F
    J Cancer Res Ther; 2018; 14(7):1638-1643. PubMed ID: 30589052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Hub Genes Associated with Cervical Cancer through Gene Co-Expression Networks.
    Deng SP; Zhu L; Huang DS
    IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(1):27-35. PubMed ID: 26415208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
    Azzahra SNA; Hanif N; Hermawan A
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2341-2350. PubMed ID: 35901340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.